Atom Investors LP Aurinia Pharmaceuticals Inc. Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.93 - $9.31 $151,143 - $285,425	30,658 New	30,658 $153,000
Q3 2020 Nov 13, 2020	SELL	$13.19 - $16.66 $3.96 Million - $5 Million	-300,070 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$14.12 - $18.33 $1.99 Million - $2.59 Million	-141,233 Reduced 32.0%	300,070 $4.88 Million
Q1 2020 May 15, 2020	BUY	$11.34 - $21.46 $1.11 Million - $2.1 Million	97,652 Added 28.42%	441,303 $6.4 Million
Q4 2019 Feb 13, 2020	BUY	$3.88 - $21.42 $1.33 Million - $7.36 Million	343,651 New	343,651 $6.96 Million

209

58.7M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.